Behind AstraZeneca’s Covid-19 Vaccine Stumble

AstraZeneca’s CEO promised more shots, at a lower price, than competitors, but now faces criticism from the EU for a production shortfall.

The Wall Street Journal | Operaciones | Salud |

Leer noticia completa en el medio original
Spanish